TEVA

Teva Pharma Industries Ltd ADR

Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.

Teva Pharma Industries Ltd ADR (TEVA) is rated C+ (2.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B); its weakest is Revisions (C-).

Quantitative Factor Evaluation • Updated

Overall Rating
2.5 / 5.0
C+
Value
C-
Factor Score 2.1 / 5.0
Growth
B
Factor Score 3.3 / 5.0
Profitability
C+
Factor Score 2.8 / 5.0
Momentum
C
Factor Score 2.4 / 5.0
Revisions
C-
Factor Score 1.9 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 57.4
EV / EBITDA 21.0
Rev Growth YoY -0.8%
Gross Margin 52.5%
Price Return 3M -2.6%
Price Return 12M 123.9%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 2.3
ROE 9.7%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-08-05 C- (2.1) B (3.3) C+ (2.8) C (2.4) C- (1.9) C+ (2.5)
2026-08-04 C- (2.0) B (3.3) C+ (2.8) C (2.4) C- (1.9) C+ (2.5)
2026-08-03 C- (2.0) B- (3.1) B- (3.0) C (2.4) C- (2.0) C (2.5)
2026-08-02 C- (2.0) B- (3.1) B- (2.9) C (2.4) C- (1.9) C (2.5)
2026-07-29 C+ (2.6) C- (2.0) C+ (2.8) C+ (2.7) D+ (1.5) C (2.3)
Page 1 of 5